Back to results
US 5,716,826 AGranted
Recombinant retroviruses
AssigneeChiron Viagene, Inc.
InventorsHarry E. Gruber, Douglas J. Jolly, James G. Respess, Paul K. Laikind
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeChiron Viagene, Inc.
InventorsHarry E. Gruber, Douglas J. Jolly, James G. Respess, Paul K. Laikind
Estimating the term…
Recombinant retroviruses carrying a vector construct capable of preventing, inhibiting, stabilizing or reversing infectious, cancerous or auto-immune diseases are disclosed. More specifically, the recombinant retroviruses of the present invention are useful for (a) stimulating a specific immune response to an antigen or a pathogenic antigen; (b) inhibiting a function of a pathogenic agent, such as a virus; and (c) inhibiting the interaction of an agent with a host cell receptor. In addition, eucaryotic cells infected with, and pharmaceutical compositions containing such a recombinant retrovirus are disclosed. Various methods for producing recombinant retroviruses having unique characteristics, and methods for producing transgenic packaging animals or insects are also disclosed.
A replication defective recombinant retrovirus construct which infects human cells and which directs the expression of at least one viral or cancer antigen or mutated form thereof, said antigen or mutated form thereof eliciting a cell-mediated immune response directed to said viral or cancer antigen or mutated form thereof within a human, and wherein said viral antigen is from a virus pathogenic to humans.
Dependencies are inferred from the claim text.